Centre for Health Science and Technology, JIS Institute of Advanced Studies and Research Kolkata, JIS University, Kolkata 700091, West Bengal, India.
Department of Chemistry, Indian Institute of Engineering Science and Technology, Shibpur, Howrah, 711103, West Bengal, India.
Infect Genet Evol. 2021 Aug;92:104874. doi: 10.1016/j.meegid.2021.104874. Epub 2021 Apr 24.
The dire need of effective preventive measures and treatment approaches against SARS-CoV-2 virus, causing COVID-19 pandemic, calls for an in-depth understanding of its evolutionary dynamics with attention to specific geographic locations, since lockdown and social distancing to prevent the virus spread could lead to distinct localized dynamics of virus evolution within and between countries owing to different environmental and host-specific selection pressures. To decipher any correlation between SARS-CoV-2 evolution and its epidemiology in India, we studied the mutational diversity of spike glycoprotein, the key player for the attachment, fusion and entry of virus to the host cell. For this, we analyzed the sequences of 630 Indian isolates as available in GISAID database till June 07, 2020 (during the time-period before the start of Unlock 1.0 in India on and from June 08, 2020), and detected the spike protein variants to emerge from two major ancestors - Wuhan-Hu-1/2019 and its D614G variant. Average stability of the docked spike protein - host receptor (S-R) complexes for these variants correlated strongly (R = 0.96) with the fatality rates across Indian states. However, while more than half of the variants were found unique to India, 67% of all variants showed lower stability of S-R complex than the respective ancestral variants, indicating a possible fitness loss in recently emerged variants, despite a continuous increase in mutation rate. These results conform to the sharply declining fatality rate countrywide (>7-fold during April 11 - June 28, 2020). Altogether, while we propose the potential of S-R complex stability to track disease severity, we urge an immediate need to explore if SARS-CoV-2 is approaching mutational meltdown in India.
由于需要深入了解新冠病毒(SARS-CoV-2)的进化动态,特别是注意特定地理位置,以找到针对该病毒的有效预防措施和治疗方法,目前新冠疫情仍在全球肆虐。由于封锁和社交距离等措施可以防止病毒传播,这可能会导致国家内部和国家之间的病毒进化出现独特的本地化动态,这是由于不同的环境和宿主特异性选择压力所致。为了解读新冠病毒在印度的进化与流行病学之间的任何关联,我们研究了刺突糖蛋白的突变多样性,刺突糖蛋白是病毒附着、融合和进入宿主细胞的关键蛋白。为此,我们分析了 GISAID 数据库中截至 2020 年 6 月 7 日(印度从 2020 年 6 月 8 日开始的第 1 阶段放宽限制之后)可用的 630 个印度分离株的序列,并检测到两种主要祖先——武汉-Hu-1/2019 及其 D614G 变体中出现的刺突蛋白变体。这些变体与 docked spike protein-host receptor(S-R)复合物的平均稳定性与印度各邦的死亡率密切相关(R=0.96)。然而,虽然超过一半的变体是印度特有的,但所有变体中有 67%的变体的 S-R 复合物稳定性低于相应的祖先变体,这表明尽管突变率不断增加,但最近出现的变体可能存在适应性降低。这些结果与全国范围内死亡率的急剧下降(2020 年 4 月 11 日至 6 月 28 日期间下降了 7 倍以上)相符。总的来说,虽然我们提出了 S-R 复合物稳定性来跟踪疾病严重程度的潜力,但我们敦促立即探索新冠病毒在印度是否正在接近突变崩溃。